Therefore, IDH2 R172 mutations can not only affect epigenetic regulation by competitively inhibiting TET2 demethylation but also enhance the expression profile of TFH and promote AITL development. This evidence concerns the gene IDH2 and angioimmunoblastic T-cell lymphoma.